PharmTech News

Articles

BPS-804, which is being developed for the treatment of osteogenesis imperfecta (brittle bone disease), has been granted orphan drug designation by both FDA and the European Commission.

Mereo BioPharma’s Brittle Bone Disease Drug Accepted for EMA’s Adaptive Pathways Program

The company announced results from a Phase II trial with its THC:CBD drug for the treatment of glioblastoma multiforme.

GW Pharmaceuticals Announces Results from Cancer Trial

The companies entered into a license agreement for Immunomedic’s antibody-drug conjugate sacituzumab govitecan.

Seattle Genetics Strikes Deal with Immunomedics

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

A total of 166 biotech executives penned an open letter expressing concern over President Donald Trump’s executive order on immigration.

Biotech Executives Express Concern Over Immigration Order

Modular Automated Sampling Technology (MAST) allows direct aseptic transfer of bioreactor samples to analytical devices, providing rapid and reliable data in bioprocessing.

Capsugel Announces Commercial Availability of Modular Automated Sampling Technology

The investment will be used to advance Nemaura’s R&D programs, which include liquid vaccines that have been reformulated for administration through the skin using its micropatch drug delivery technology.

Nemaura Pharma Receives Funding to Develop Biologic Micropatch System

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

According to results from the FOURIER trial, Repatha significantly reduced the risk of cardiovascular events and death in patients with atherosclerotic cardiovascular disease.

Amgen's PCSK9 mAb Shown to Protect Against Heart Attack and Stroke

A change in the tax code could help the company create more jobs in the United States, while fewer FDA regulations could help reduce drug prices, according to Pfizer CEO Ian Read.

Pfizer Reacts to Trump’s Comments and Discusses Pipeline in Its Q4 Earnings Call

Novo Nordisk entered a research collaboration with the University of Oxford focused on Type 2 diabetes.

Novo Nordisk Collaborates with University of Oxford

Lek, a Sandoz company, adds capacity to its plant in Prevalje, Slovenia.

Bio/Pharma News